Allende & Brea advises major domestic and international clients in the pharmaceutical, medical devices, and food industries on a wide range of matters, from incorporation and registration with state health authorities to M&A, joint ventures, reorganisations, and commercial agreements, such as manufacturing, licensing, and distribution contracts. It also supports clients with regulatory compliance, data privacy, and dispute resolution, including administrative proceedings before food and drug authorities. Following the mid-2025 departure of former co-head María Morena del Río, the practice is currently solely led by Fernando Martínez Zuviría, who focuses on supporting laboratories and medical device manufacturers with transactional, corporate, contractual, and regulatory matters. The team’s expertise is further strengthened by Vanesa Fernández, who specialises in life sciences administrative and regulatory issues, and Lucrecia Re, who represents pharmaceutical and medical device companies in regulatory and administrative proceedings.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'The practice of Allende & Brea is distinguished by its comprehensive and proactive approach to resolving legal matters.'

  • 'What makes this practice unique is the combination of knowledge and experience.'

Key clients

  • DSM-Firmenich
  • Aspen Labs

Work highlights

Advises DSM-Firmenich on the separation of its animal nutrition and health business unit in Argentina.

Lawyers

Next Generation Partners

Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Practice head

Fernando Martínez Zuviría

Other key lawyers

Vanesa Fernández; Lucrecia Re